Stock index futures slide on Thursday.» Read More
But use of Merck& Co's widely prescribed Zetia, which is not a statin, and Vytorin, a related drug, will likely not be badly hurt anytime soon, analysts said, because doctors will need time to understand and accept the new guidelines. The Merck drugs have combined annual sales of more than $4 billion, or 10 percent of overall company revenue.
Pfizer Inc, Amgen Inc and a partnership of Regeneron Inc and French drugmaker Sanofi SA are racing to develop the new family of medicines called PCSK9 inhibitors. "I read the new guidelines as a negative for any drugs that aren't statins, including PCSK9 inhibitors," said Jon LeCroy, an analyst with MKM Partners.
Focused on high-risk heart attack and stroke patients, the new recommendation are for aggressive drug therapy to lower cholesterol.
The number of planned layoffs at U.S. firms rose 13.5 percent in October on cuts in the pharmaceutical and financial sectors, a report on Wednesday showed.
"Mad Money" host Jim Cramer made calls on stocks viewers asked about.
LONDON- Even as the euro zone economy shows faint signs of stirring, the European Central Bank is likely to send a dovish message this week that more monetary help will be on the way before long. Embraer probed for bribery in Argentine, Dominican deals.
DALLAS, Nov 3- For more than a century, ranchers and their children have paraded cattle around the dusty show ring at the State Fair of Texas in Dallas, in a rite of passage that is part farm economics, part rural theater.
Oct 31- U.S. pharmaceutical giant Merck& Co faces significant challenges bringing its controversial feed additive Zilmax back to market in the United States and Canada, even after a vote of confidence from South Korea on Thursday.
*South Korea currently bans controversial animal feed zilpaterol. SEOUL, Oct 31- South Korea plans to end its ban on the animal feed additive zilpaterol early next year, a senior food ministry official said on Thursday, opening the door to beef imports containing the growth enhancer and its domestic sale.
CHICAGO, Oct 30- Cargill Inc, one of the world's largest beef processors, threw a wrench into Merck& Co.' s plans to reintroduce its feed additive Zilmax, stating it will not accept Zilmax-fed beef into the Cargill supply chain "until we are 100 percent confident the animal welfare issues are resolved."
CHICAGO, Oct 30- Agribusiness giant Cargill Inc said on Wednesday that it will not buy cattle fed Merck& Co Inc's controversial cattle-feed additive, Zilmax, and will not feed it to its own cattle, until it is "100 percent confident" the animal welfare issues are resolved.
Oct 30- Parexel International Corp's shares fell as much as 18 percent after the drug research services provider said it struggled to win new contracts when rivals reported strong results and raised their forecasts.
CHICAGO, Oct 29- U.S. drugmaker Merck& Co told Reuters on Tuesday that it plans to bring its Zilmax animal feed additive back for sale in the United States and Canada, after it completes an audit of how the muscle-building cattle feed product is used in the agriculture sector.
CHICAGO, Oct 29- Cattle are entering U.S. packing plants slightly thinner than a year ago as feedlots rush the animals to market to cash in on record-high prices and are no longer feeding them the growth promotant Zilmax, analysts and economists said.
*Apple shares edge up ahead of results. NEW YORK, Oct 28- The S&P 500 closed at another record high on Monday as expectations were high that the Federal Reserve will keep its stimulus in place when it meets this week.
Stocks were slightly higher Monday, with the S&P 500 pushing to a fresh high, but gains were limited as investors digested a batch of mixed earnings reports and ahead of the Federal Reserve's policy-setting meeting.
*Apple shares edge up ahead of results. NEW YORK, Oct 28- U.S. stocks edged higher on Monday, pushing the S&P 500 to another intraday high, with expectations high the Federal Reserve will keep its stimulus in place for the time being.
NEW YORK, Oct 28- U.S. stocks were little changed on Monday as investors found few catalysts to push equities higher after the S&P 500' s latest record high.
NEW YORK, Oct 28- U.S. stocks were little change on Monday as investors found few reasons to keep pushing shares higher after the S&P 500 climbed to a series of records on expectations for continuing Federal Reserve stimulus.
As earnings season hits halftime, there are three themes emerging.